The relationship between PG-SGA scores and nutritional status of patients receiving chemotherapy

Main Article Content

Dilşat Baş
Özlem Sönmez
Nilay Öngen
Elif Şenocak Taşçı


PG-SGA, Nutrition Education, Cancer, Malnutrition


Background: We aimed to examine cancer patients receiving chemotherapy in terms of nutritional education status, malnutrition rate, and use of oral nutritional support. The relationships between these variables are explored.

Materials/Methods: PG-SGA malnutrition screening tool and questionnaires about nutrition education status and oral nutritional support were carried out with 281 cancer patients treated in the chemotherapy unit of a private health institution. The data were analyzed with SPSS.

Results: We found that 56.1% of the patients received their nutritional information from the doctor. There was not a significant relationship between nutritional education status and malnutrition. According to the PG-SGA evaluation, 37.7% of the patients were moderately malnourished and 6.8% were severely malnourished. However, it is seen that 72.5% of malnourished patients do not receive oral nutritional support. The PG-SGA results revealed that Albumin was significantly lower in patients with severe malnutrition compared to other groups. It was found that malnutrition was overlooked in 82% of patients evaluated with BMI alone.

Conclusion: PG-SGA is a tool that should be used routinely with chemotherapy patients. In future research, the validity of the PG-SGA short form should be conducted as it may provide ease of application and widespread use.

Abstract 269 | PDF Downloads 296


1- Union for International Cancer Control. GLOBOCAN 2020: New Global Cancer

2- Andreyev, H.J.N., Norman, A.R., Oates, J., Cunningham, D. Why do
patients with weight loss have a worse outcome when undergoing chemotherapy for
gastrointestinal malignancies?. Eur. J. Cancer 1998;34(4), 503-509.

3- Sørbye, L.W. Cancer in home care: unintended weight loss and ethical
challenges. A cross-sectional study of older people at 11 sites in Europe. Arch Gerontol Geriatr 2011;53(1), 64-69.

4- De Groot, L.M., Lee, G., Ackerie, A., van der Meij, B. S. Malnutrition
screening and assessment in the cancer care ambulatory setting: mortality
predictability and validity of the patient-generated subjective global assessment short
form (PG-SGA SF) and the GLIM criteria. Nutrients 2020; 12(8), 2287.

5- Mendes, N. P., Barros, T. A. D., Rosa, C. D. O. B., Franceschini, S. D. C. C. Nutritional screening tools used and validated for cancer patients: a systematic
review. Nutr Cancer 2019; 71(6), 898-907.

6- Bozzetti, F., Mariani, L., Vullo, S. L., et al. The nutritional risk in oncology: a study of 1453 cancer
Outpatients. Support Care Cancer 2012; 20(8), 1919-1928.

7- Bauer, J., Capra, S.,Ferguson, M. Use of the scored Patient-Generated
Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients
with cancer. Eur J Clin Nutr 2002; 56(8), 779-785.

8- Isenring, E. A., Banks, M., Ferguson, M.,Bauer, J. D. (2012). Beyond malnutrition
screening: appropriate methods to guide nutrition care for aged care residents. J Acad Nutr Diet 2012;112(3), 376-381.

9- Arends, J., Bachmann, P., Baracos, V.,et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017; 36(1), 11-48.

10- August, D. A., Huhmann, M. B. American Society for Parenteral and Enteral
Nutrition (ASPEN) Board of Directors. ASPEN clinical guidelines: nutrition
support therapy during adult anticancer treatment and in hematopoietic cell
transplantation. J Parenter Enteral Nutr 2009; 33(5), 472-500.

11- Ottery F.D. Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Semin Oncol 1994; 21:770–8.

12- Bauer, J.D, Ash, S., Davidson, W.L, et al. Evidence based practice guidelines for the nutritional management of cancer cachexia. Nutrition and Dietetics 2006; 63(Supp. 2), 5-32.

13- National Collaborating Centre for Acute Care (UK). Nutrition support for
adults: oral nutrition support, enteral tube feeding and parenteral nutrition. Accessed November 21, 2022.

14- Akmansu ,M.,Kanyılmaz, G. (2021). Malnütrisyon Taramasındaki
Yöntemler: Hangi Yöntemi Kullanalım?. Turk J Oncol 2021; 35(1).

15- Arends, J., Bachmann, P., Baracos, al. ESPEN guidelines on nutrition in cancer patients. Clin
Nutr 2017;36(1), 11-48.

16- De Groot LM, Lee G, Ackerie A, van der Meij BS; Malnutrition Screening and Assessment in the Cancer Care Ambulatory Setting: Mortality Predictability and Validity of the Patient-Generated Subjective Global Assessment Short form (PG-SGA SF) and the GLIM Criteria. Nutrients 2020; Jul 30; 12 (8): 2287.

17-Schneider SM, Correia M. Epidemiology of weight loss, malnutrition and sarcopenia: a transatlantic view. Nutrition (Burbank, Los Angeles County, Calif) 2020;69:110581. doi: 10.1016/j.nut.2019.110581.

18- Arribas L, Hurtós L, Sendrós MJ, et al. NUTRISCORE: a new nutritional screening tool for oncological outpatients. Nutrition 2017; 33:297–303.

19-Abbott J, Teleni L, McKavanagh D, Watson J, McCarthy AL, Isenring E. Patient-generated subjective global assessment short form (PG-SGA SF) is a valid screening tool in chemotherapy outpatients. Support Care Cancer 2016; 24:3883–7.

20. Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002;56:779–85.

21. Isenring E, Bauer J, Capra S. The scored patient-generated subjective global assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 2003; 57:305–9.

22. Shaw C, Fleuret C, Pickard JM, Mohammed K, Black G, Wedlake L. Comparison of a novel, simple nutrition screening tool for adult oncology inpatients and the malnutrition screening tool (MST) against the patient-generated subjective global assessment (PG-SGA). Support Care Cancer 2015; 23:47–54.

23- Isenring, E., Cross, G., Kellett, E., Koczwara, B., & Daniels, L. Nutritional status and information needs of medical oncology patients receiving treatment at an Australian public hospital. Nutr Cancer 2010; 62(2), 220-228.

24-Zhang, Q., Li, X. R., Zhang, X., et al. PG-SGA SF in nutrition assessment and survival prediction for elderly patients with cancer. BMC Geriat 2021; 21(1), 1-9.

25-Baracos V.E., Martin L., Korc M. Cancer-associated cachexia. Nat Rev Dis Primers 2018;4:17105.

26-McMillan D.C. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013;39(5):534–540.

27-Arends, J., Strasser, F., Gonella, S., et al.Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆. ESMO Open 2021; 6(3):100092.

28- Muscaritoli M., Arends J., Bachmann P., et al. ESPEN practical guideline: Clinical Nutrition in Cancer. Clin Nutr. 2021;40:2898–2913.

29- Zirpoli, G. R., Brennan, P. M., Hong, C. C., et al. Supplement use during an intergroup clinical trial for breast cancer (S0221). Breast Cancer Res Treat 2013;137(3), 903-913.

30- Gröber, U., Holzhauer, P., Kisters, K., Holick, M. F., Adamietz, I. A. Micronutrients in oncological intervention. Nutrients 2016; 8(3), 163.